OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

REGISTERED CHARITY NUMBER: 290959 REPORT OF THE TRusfEES AND iJNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025 FOR BRITISH GYNAECOIA)GICAL CANCER SOCIETY

BRrrIsH GYNAECOLOGICAL CANCER SOCIETY coiYrEiYfs OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025 P88e Report ofthe Trn$te¢s I to 7 ltt¢tep¢nd¢nt ExiThln¢r's Report S¢¢¢meDt of Finnti#l A¢tlvltl BAlante Sheet io Cash Flow Sta¢eme￿I Notej to tbe C￿h Flow StstemeDI 12 to the FinaneiAI Ststements 13 to 19

BR￿lSH GYNAECOLOGICAL CANCER SOCIETY REPORT OF THE TRUSTEES FOR THE YEAR Ef4DED JI DECEMBER 2025 The Irustees pr¢$¢nl their report with thr f]llaDrial st￿tt￿ent% of Ihc charity for the year ended 31 DcceJnbBr 2025. The stees have adopted the provisioDS of Accounting and Reporting by Charities.. Ststemcnt of RccoTllmended Pra¢ti¢e applicable to chariiics preparing their accounts in ￿cOrdan¢e witb the Fina￿la1 keporting Standard applicable in the UK and Republic of Ireland (FRS 102) Icffe¢tive l JaThu￿ 2019). OBJECTIVES AND ACTIVITJFS Objeetlves and alms The objects of the charity are lo advunrE the s¢i¢nc¢ and art of gYj￿0]08lC8l oncology for tIK beJ]¢fLt of the public. The Brilish G￿ae(oloBlCaj CgJJG¢T Society {BGCSI se¢ks to acthieve these objectives by.. - MakiThg grant5 to individuals aTKi supptirting rese8rth in 8ynaecolo8ical ottcology. - Sponsorin8 and un(krtaking r¢sear¢h relcvanl to th¢ prevention. dia8rK>sis and treathjrnt of gynae¢ologt¢81 c8wers. - ProvidiDg advocacy. prOt￿lOnal advice and information. - RuJ]niDg con5en5U5 pior¢ss¢s and me¢lin¥s on important a￿a5 of gyna¢cological caTK¢rra￿, - Developing and publishi08 clini¢al guidelines for the dLBgIK)5is arKi managemeht of g>￿&t￿l0￿c￿ ¢an¢¢rs. - Working with the Royal Coll¢g¢ of Ob5tsrrieian5 and G)maecologists (RCOG) and Nh¢T prof¢wional organisations to support d¢velopmentof tr4inin8 ¢uryi¢ula and surgical skills. Supporting ihe professional development of members 8T￿ th¢ WKler mullidiscipliDary W0￿roT¢¢ involved ID gynaecological cancerc4re. - Aciing as an w)Jbrelia and rtsource body for prof¢ssiOt*ls involved in gyrw¢wlogi¢al oncology. - Supportin8 an annual scieDtific meetiDg ¥ddr¢ssing impoMI d¢v¢lopments in gynaecological o￿￿10gy. - Awardin8 prizes for hi8hsuality SCLelJtkfK work pr¢s¢nted at the Annual Scientific Meeting. - Supportin8 trainees ar￿ subspeciality fellows through cdvcational aclivitie& r¢scoTch 8r&nts aThJ otheroppornnitie& blk b¢nefrt The trustees confirm that t￿Y hav¢ tvf¢tted to the 8uidance contained in the Charity Commission's suidat￿t on public benefit wheTh revi￿￿7￿8 the ChRriW5 aims and (pbj¢¢tiv¢s aml in plan￿n8 fL]b]re activities. The trustce5 C0115ider thAt the Srtietys a¢tivit1¢5 provide publtc bcncfii by promoiing edu¢ation, r¢sear¢h, profts8ional developn]¢nt Ènd improvements irt the quHlity of care pl0vid￿ to PEDple affetled ty gynaecological Cancers. P4ge I

BRITISH GYNAECOLOCICAL CANCER SOCIETY REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECKMBER 2025 ACHIEVEMENTS AND PERFORMANCE Tbe BGCS continued to develop and exp&￿1 during 2025. reflectin8 the inw¢asingbr¢•dth of the SDciety8 activiti¢s 8nd its membership across the multidis¢ipliThary PTvfcs5ion8 involved in 8ynattolo8i¢al canrwrare. Tbe prirKip81 aijrs of the BGCS remain to a¢fvo¢ate for hi8h-quality &ynae¢ological catw seNAces, pmmote education and rese￿h. support the h¢8lth¢ate PT0fe$5i￿a]s involved ID deliverin8 Ih¢se service& and ellcoura8e best practice in the diagnosls. tream?enl and care ofpeople affected by gynae¢ologieal canrxr. Annu81 &l¢mtir￿ MeftSng Th¢ 2025 BGCS AEJnual Scientific Meeting w held in London aTKI a succe&rful sci¢ntifi¢ and thational mectin li attract¢d 565 d¢legat¢s, with pr¢sentstions from national and itbt¢rn81ional spe&k¢rs coveriftg a broad Tang¢ of developTtaents in 8yDaecolo8ical cancer. Tbe meeling rcturned a small fjnattial sllrplus. The Briti5b A55ociation of Gym2ccological Patholowsts (BAGP) held a parallcl mceting alongside th¢ BGCS Antwal Scientific Meeling. This further Stren￿￿£￿￿ Jlliunc¢ bctween the two organisalions a￿1 eTrcourag¢d closcr multidisciplinary roll3boTrtion between g￿LaeCo10gic￿l onwlogists and Sp￿la11$t gynaecological pathologists. The oext BGCS Annual Scientific Meetlll8 is planned to tsk¢ place in Bristol in Jwi¢ 2026. Trglnees and mbspeclllty fEIIows Supporting the next generntion of gynaecologirdl o￿OI0￿1$1S remains & majorpriwity for Society. The BGCS held a surc¢ssful rneeting ill January 2025 6pecifi¢4lly fot ¢rain¢e5 and gynaecological oneolo8y subspecialty fellows. The m¢eting provided edu¢atio#al. professional developrt￿llt and networkiilg opportunities and enabled tyginees ty diSa￿S is5u¢s relevarjl to thetr training and fuwrc careers. The Society Continues w support subbirialty fellows and nuintaiThs ¢los¢ links with the Royal College of Obstetricians and Girywcologi5t5 in ￿lation ¢0 sub5p¢cialty training. The BGCS is Cot￿¢10￿ that the￿ are CUryEntly a signifjcant llum￿r of Consultant vacancie5 wiihin UK gymae￿IQBl¢8l oncology services and that appropriate workforcc plaDnin8 and the tt8inin¥ of suffirient nufflber5 of future consultants important to mainrainin8 high-quality gynaecological cancer services. The BGCS Sub$￿101ty 8roup therefore continues to liaise ¢lo$¢ly ￿7th th¢ RCOG to assist with dccision-njaking and workfor¢¢ planning in this area. Vnlt gynaetoloiists The Society held a SUCCL8RfiJl ftwing in Bimiingham for Unit Gynaecologists with a Special Interest in Gymaecological Cancer. Supportins clinician$ workin8 io ¢anc¢r uniis 1ernain5 an part of the Swietys work. These medings facilit8 ucation, comrnunscation belwEen can¢eT Unlts and ¢anr¢r centre5. disscminatioTh of best pra¢ti¢e and discussion of the pArticular dwll¢n8es faced by clinicians mmawng patients with 8yrAttotogi￿l utK¢routside specialist cancer centres. Rese#rch grants The BGCS continues lo provide rjA￿￿111 supw¥rt for gYna￿OI081Cal CaDcer research and to en¢owoB¢ research activity amoTLg5t trainee8 and other member5 of the Swiety. During the year. the Society offered research gratrts ¢0 trainees and other eli8ible appli￿n¢$. These included grants administered ditectly by the BGCS as well as ¢0118borntive grw)Is with Wellbein8 of Women. Applications for BGCS rts¢aroh 5UPPOrt conlinue lo dett)DtJsirnte the importance of providio8 QPPOrtunities for traiTJ¢es and other ffseaTrher5 to develop re￿reh projects in 8YThae¢ologi￿7 cancer. Collibortion with gyMec4)IoElcg1 tancer ch8rltles The BGCS continues to work ¢loyely with ¢h8rities rep￿Senting and supporting p￿pIe affected by 8yIKeeolo8ical cancers. Regular rncctin85 llTe held wth other 8)ryv¢oIo8ical ￿t￿er cknritie5 to ensure that imp)rtant issues aff￿11￿8 Patients Dd gjnaecological caT￿tr 8eTvices C￿ wh¢T¢ appropriate, be addressed nationally in a coordinated and eohesivc manner. Owdnisation$ participating in these di8cyssh)ns have I￿l￿ded W¢Jlbeing of Women, The Eve App¢AI, Pehches Womb Cancer Trust. Target Ovarian CanLrr, Ov8come and Ovarian Cancer Action. Th¢s¢ ¥¢l&tionships provide #n important mecbanism for ensuring that tlle PTofe&sional rtr4Jectivt of the BGCS inforn]ed by the exp¢ri¢nce5 and prioritics of patients atNI the organisations representing thenL aini¢al guideli1￿ and c¢)nsellsus development Page 2

BRrrisH CYNAECOLOGICAL CANCER SOCIETY REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025 The BGCS Guidelines Group coMinu¢d its work during 2025 on the development and revision of clinical guidelines. including the Swiety'¥ Lmical ¢JJJ¢¢r¥uideliThes. The d¢v¢loptn¢nt of ¢vid¢nc¢-based 8uideliThe5 remain5 a core activity of the Society aTKi suNN)its th¢ BGCS objective ofpromoting ¢onsn¢ high4wality care for patients with gY￿e¢O]0g1Ca] CAncer ihroughoul the UK. The Society also initiated a Delphi con5ensu5 pr(￿55 COllC¢tniug th¢ introdu¢iion And use of hyperthem)i¢ i￿￿peri1￿ntg1 ¢heny)therapy IHIPECI ill OV￿1a￿ can¢et. The pwpose of thi5 pmcess is to establish expcrt cotbS¢nSUS ¢on¢¢min8 the appropriate introduction and delivery of HIPEC 8nd to pn)vide 8uidance for clinLCl8f15 a￿j 5erYi¢¢$ con$id¢rin¥ its impltmentaiion. The Society anti¢ipat¢s t￿t the r¢Suliingcons¢ns￿ statement will be cotnpletd 8tyJ am)ouDced durin8 2020. Syrglcgl Sk1115 Projeet Durin8 the year. BGCS ro113borkted with the Royal Colle8e of Obsletriciarfj and Gynactologists and other relevant profc55ional 5(KiCties on a Surgi￿1 Skills Projert. The project seeks to identify the surgirni sil]s and trdiDing requiren￿nts that will be n¢¢¢ssary for fvture generitioTh¥ of gynaecological surg¢on5 to ¢onsid¢r how appropriaie SUTgical training ¢ath be d¢liveTed in the context of changing clinical pra¢ii¢e, technology and W0￿f0rcC requirements. The BGCS considers maintenance atKi developtncnt of high-qu￿tty surgical hining to be fuTrJ&rncntal to the bjture provision of safe and etTective 8yJaecoloÈical ¢an¢¢r sutg¢ry will conlimje to contnljute to this work. E•dometrlal ¢8Tr¢er •udlt The national endometrial cancer audit, u[￿ertaken in collaboratiott with the National Di5e8se Registration SeJvi¢e INDRSINCRASI, Peaches Womb C￿n￿r Tritst, The Eve Appeal at￿ the British As80ciation of Gyna¢wlo8ical Patholo8LSts. publishcd the first rerA)rt. Th¢ a￿li1 represents an ifflportani pi¢¢¢ of work ¢XarniTUTh¥ Ihe manJ￿rnent of endomeliial Fancer and provides inforn?ation that can be used tQ uT￿etstand variation in practice and identify opp)rwnities to improve the quality and con5jStency of car¢. Following the s￿¢¢¢5$fvl ¢ompl¢tion of this worK th¢ BGCS is seeking fwmling to und¢n4k¢ a similar natiDTMI audit of vu]val canr¢r. Internat10￿81 Gyn8etologieal C•n¢tr So¢iely The BGCS has maitttained a relationship with the Iniernaiional GyMe¢olo8ical Cancer Society (Ica), following Strategic alliar￿e e5tBblish¢d PTtviously. In light of the developjnetrt of Ihe BGCS and ihe ¢han¥ing r¢quirem¢nt$ of lis n￿￿be￿ipl the Swi¢ty has decided to review sts relationship with th¢ IGCS. This review will con5id¢r the bencfits Provided to BGCS m¢new& opportunitie5 for international education and Collaborntion, and whether the current arTangeinetts COniinu¢ to repfesent an appropriatc of the Societys resourL% Any future a￿an¥ementS will b¢ d¢t¢rmined followingcompletion of thi5 review. FINANCIAL REVIEW nanci*l pwlllo The Charity incurred a net deficii over in¢om¢ of £110,721 in th¢ yrdr (2024.. 8 nct deficit of £89,376), th¢ff was 3 deficit of £97 J610Th unrestricted fijnds and a TWt deficit of £13,360 on Testricted fund5. As at 3111212025 the unrestricted fvnds St(￿ at £435,502 12024.. £532.863) and restricted funds si(MJd at £nil (2024.. £13J601 and this included b2Trk balance5 of £421.558 12024.. £513,278). The iTU5tee5 Co￿lJ¢r the fiDancial ￿}sitiOn of the rhwrity lo be ￿tisfaCtOry. Page 3

BRrrisH GYNAECOLOGICAL CANCER SOCIETY REPORTOF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025 FTNANCIAL REVIEW Reseryes pol(cy Thc Tr¢a5urer will monilor tbe financial resetves of the charity and is responsible for reco￿ & r¢setves polL¢y which will be reviewed by the Trustees on an annual basis. The curreTht reserv￿ ￿lIcY wa$ agr￿￿ at th¢ cowi¢il meetiny in JuDe 2017 and is based on the followryt)g princip&ls.' -The BG(S should keep reserves that can the working of the charity for a year. -Th¢ BGCS should not keep reserves ihai are excessiv¢. Assuming the Tequirement for Thint4ining regerv¢s for on¢ year is ¢he Gharity should avoid k¢epin8 reserves ￿ater than 80% of the stmi of ihe annual in¢ome a]Ml ¢xpenditwe av¢raged over five yel -Wh¢n JYs¢rvts are excessive. the chBrity shou]d explore new avenues of ¢hrritablE activity. Under th¢ curtEni res¢)w¢s poli¢y resaves ai the ye4r ¢Dd c¢)ntinue to b¢ hith d¢spi p1W￿EdexrR[YJiIllre on funding th¢ feasibility pilor of 2 National ErtdometriAI Cancer Audit Pilot (ECAPI. fu]thtr expcnditurt on the Webinar educalionai programm¢, fimding of 2 ¢ons¢nsus meetittg5 and funding of an additional sub-group. In 2020 Council &y¢ed additional spetmling to wpw)rt Traine¢wTrdiners Annual Sunllnii discount¢d Jrgistration fees to suppori nurse members attending Annuol Scientific Meeiing, increased expeThditur¢ on PTiZ¢S. owards, ￿¥¢1 fellowsthips aThl researchlaudtt grants. FUTURE PLANS During 2026. the BGCS irtends to COAlinwe and develop its adivities, including: - HoldiD8 th¢ Annu#] ScieMifi¢ M¢eting sn Btislol ID June 2026. - Electing the s￿Iety's first Vice Presid¢nt utmler the revised governance structure. - Continuing development of thc c¢rvi¢al ¢atKerguidelines. Cvmplcling the Delphi conwh5us process relating to HtPEC in ovarian canccr. wryth the intenlion of publishing or announcing the eoThsensus stameni before the end of 2026. ContimiiDg to 5UPWt trainecs and 5ubspxi&lty fellows and contsibuting to diseussiofL5 r¢gardin8 the 8yD8ecological oncolo8y workforce. - Continuing roll3bortion with the RCOG and oiher societies ort the Surgiul Skills Proje£t. - Continuing Tcsearch grant prOgranU￿￿. i￿luding ¢ollaborntiv¢ fimdthg with Wellbeing of Women. - Reviewing th¢ Soriety's relationship wiib the lThlernational G￿)1¢¢0]081¢Jj ca￿¢[ Society. - Continuing ￿gular engagenientwith national 8ynattologi¢al tsnr¢r thaTitifS. - Seeking fimding forthe development of a national vylvsl c8D¢¢r audit. - Continuing to d¢v¢lop the BGCS'S role in promot?n8 hiBWualtty. evidenctrbased and equitabl¢ 8yM¢wlogical ¢anc CaTe throughout th¢ Unii¢d Kingdom. - EsthblishmEnt of annual Fnuliidisciplinary Vulva s￿O51w)L The InJsl¢¢s consider thgt the a¢livilirs will fiJrtTr￿r thc charitable objectives of th¢ BGCS and cnbance the Society, ntribution to impTowng oth¢omes atld care for P￿pIe affe¢td by gyJw¢ologt¢al cancer. STRUCTURE GOVER14ANCE AND MANACEMENT Goverulng d•tuthent The ¢hgrity is Controlled by its governing document. a deed of tru5¢ and ¢onstitytes an unincortM)fdtcd charity. The British Gyn8#olowcal Cancer Society i5 con51Ltuted und¢r a deed odopied Ai the time of thE inaugural m¢eting on the 6th October 1984 and amendd on th¢ 6th May 1988. 30th April 1994. 20th May 2004 atwj 21 JurK 2013. It is re8lStered charity, numb¢r 290959. Page 4

BIUTISH GYNAECOLOGICAL CANCER SOCIETY REPORT OF THETRUSTEES FOR THE YE4R ENDED 31 DECEMBER 2025 STRUCTUR4 GOVERNANCE AND MANAGEMEr Ckarlty ¢ons¢ltutlon Tbe rnng¢ and volume of activities undertakets by th¢ BGCS have increased con5idcrably iaj r¢G¢nt years. These inct￿le ¢du¢atiothal meetin85. 8ULdeline d¢￿]￿p[￿¢￿1, rwrch 8rants. national audils. cngagement wilh patient charilie workforee issues. profe55ional advo¢aey artd ¢ollabor8tioD with other national and international org8r￿$￿tI0￿s. InTeco￿lt10n of this increased worklo&d, the Society agreed a rcsolution to )mend its ¢onstitutioTh so that the BGCS will F¢nron¢ntly have fourOffi¢ers raib¢rthan three. The additional Officer will hold th¢posiiioTh of Vice Pre5id¢nt atNi will also s¢rv¢ as an additionAI tr￿tte of the So¢i¢ty. The pu0￿S¢ of this ¢hang¢ is to illcrease the leadership and govenwi¢e capacity of the Society and to di51nThu* the increasing workload ￿n￿ngSt 8 largcr Officergroup. The first Vi¢¢ President under thc new aTrangeTJftts is due to be elected in JurK 2026. The suc¢essfvl ¢wJdidate will 5¢TV¢ for two years as Vice Prcsideth followed by a fillth¢r hvtryearterni as Pre5ideni. Th¢ trustees b¢li¢ve that this ehange will stretigth¢n coniinuity of leaderships suc¢ession plat)niJ]8 4nd governanLe witbin the BGCS wthile providing additional capA¢iry to supp)rt ihe expanding adivit1¢5 of th¢ Society. RecndtrneDt xppointment of ttew trngtees The olfice holder5 of the Society (P￿sIdent. Hon S¢¢retary 8nd Hon Treosur¢r) have 8Utomaiically held the role of Trustce since the inception of the Society in 1984. It wa5 decided tsi ai th¢ sumtrw council me¢ling of Ihe soriety on 8¢h July 2015 that th¢ ￿ciety should formaliBe the appointTnenl of non£xe¢uuve trustees aTML thi5 wa5 ralifi¢d at the AGM of l(hh July 2015. It wa5 decided that tTr￿ offica¥ of the cowieil as described in the eonthwtion of the BGCS 2015 Section131 would be Join￿ in the role of tru5ters by no less thwj ¢wo 8nd no more than four non-volin¥ trustees to s¢tv¢ for threc ye4r8. The aim of council to seek applications fTOTn the t1￿￿¢ ￿￿￿1¢n¢¢4 I￿lIvidual$ witkn'n the rnernb¢t5hip and ir wa5 ¢nvisaged that such Candidates would be either nearing th¢ cnd of or hav¢ r¢tiTd ftorn clinkcal a¢tic¢. The memkr5hip was a5k¢d to self nominare for the position or nominate a colleague if Ihcy were agtyttable to taking up the rA)5ilion. by OctobEr 315t 2015. Subsequently two individua15 were identified who w¢re approached and who both accept￿ the position of truslee. TheLT appDintm¢nt was ratified at AGM of 15th May 2016. The n¢wly appoinwl m]st¢es 5Ent invitsiion l¢tt¢T whi¢h directed thellL ￿ background reading regarding their 5ta¢ulory and Socsety responsibiliii¢s. Both trustees accepted by rrturn of posl. The fjrst responsibility delegated to the two n¢wly appointed tW5tce5 Was the recruitment of a third Tlon voting Ir￿1¢¢. id¢t)tifi&l at the council [r￿Cting of 9ih Febnmry 2017 8nd subsequently directlyapproachtd wih ihe ￿rne invitation Ictter used pr¢viowly. The third noD.voting trustee accq)ted the posiiion fornmlly on 13th March 2017 aTwJ ihis 8ppointm¢llt wTrs ratified at the AGM on 15th June 2017, thi$ p¢rson has now stepped down from th¢ tsvsree position for PCT50Dal r¢Rsons at the end of 2020. A new IT￿￿￿¢c with a JKpn mdi¢al background and experti% in l¢gal affairs has sitte been appointed. The current constit￿lOn(20l7I states in relation to truslee&- Section 2 (Membership of the Society) Trustees I. TNsÈees are r¢quir¢d by the Charity Commission. l Tnjstces shall be r¢eomm¢nded by Council and ralified by the AGM. 3. Twst¢¢S shall Serve a miniiniim i¢mi of three years and thi5 ierm may b¢ re[￿ble for up ￿ two further tenJLs. certain CiTEwn5tan¢es th¢ terni may be extenthd by E further one year to allow for overlap and ensuring Suitsble candidates are in post to provid¢ cojjtinuity to the Society. 4. There $h811 be a minimum of 2 and a maximum of 4 tNst¢¢s will r￿1 have voting rights. 5. Trust￿5 shHII b¢ individuals WI￿se qualificJ¢ioD$ and ]￿livatIon would be of value to th¢ BGCS in P￿rn01]ng its goals within the rnks of its charitsble siatus. Rlsk man8geme Th¢ trustees have a duty to id¢niify and review Ih¢ risks to which the Clwity is exposed aDd lo ertsure appropriat¢ contro15 are in place ¢0 provide ffasonable assuTance against fraud and error. Pagc 5

BRITISH GYI¥AECOLOGJCAL CANCER SOCIETY REPORT OF THE TRUSTEES FOR THE YEAR E￿,DED 31 DECEMBER 2025 STRucfuRE GOVERNANCE AND MANAGEMEf4T Overnjl Performinte Overall, the trustees consider that the BGCS continued to a¢hi¢ve its rharitable objcctiyes successfillly during 2025. The Society r¢tnaiTr5 8 thriving multidisciplinary or8anisation with art expanding role in education, reseaff]4 guideline deve]opm¥Dt, c]ini¢al audiL profe55ional trdioing. work(¢)rc¢ planning aThl Ad¥oca¢y for hi8h4wality 8yJ¥8ecologi¢#l cancer C￿%. Th¢ suc¢essfvl Annual Seientsfic Me¢tin& dcdicated meetings for trainees and Unit 6￿a¢COlo¥i5ts, cijntinued reSea￿h fundin8. publi¢&tion of the MtionAI endometrial Cal￿er audit. developm¢ni of clinscal guidcline5 and CO￿￿¢￿%￿8 wor( and intreatsing ¢ollaboTrtion with prof¢5sional b￿leS and patient ¢haTities demJ]strate the breadth of the &xiety'8 Sctivities. The tnjstees reco8nis¢ that th¢ increasing ￿CtivItIeS of the Society also create additionAI govern#￿e and athninistr4tive responsibilities. Th¢ ¢onstityiional ¢hAnges ¥￿ted during the ye4T arc intsndd to that Ihe Society has atL appropria1¢4dership SIn￿lUre to support ihi5 gTOWIh. The BGCS will ¢ontit)u¢ io work Nryth its mell]be￿ the Royal College of Obs￿￿1¢1&￿$ atyj GY￿¢0]0￿15t￿ other Or￿lOnal societies, patient thatxties al￿ national oYganistK)n$ to improve th¢ diagnosis tr￿tMent and Caye of people affeetrd by gynaecologjcal cancer. REFERENCE Af4D ADMtNISTRATIVE DETAILS Reglstered Ch8rlty ThurA￿r 290959 Prlntlphl Addre GI￿} Ffordd Y Parc Parc Mcnai BangoT Gw)Tredd LL57 4FE Trust￿8 Mr S C Lee50TL{apwinicd 29.126) MF C Cban Iresi¥ned l.1.261 Proft550r J Shepherd (resi￿d l.1.26) M$BRai MT S Dobbs (resigned 10.7.25) Mr A J Phillips- (Secreiary) Mr K B GO￿ar (resigned 10.7.25} Drw D G Rathavelu- {Tr￿￿re[l (&pp)ind I1.7.25) T E J Ind - (President) (appoint¢d 10.7.25) Prof M Wells {appointed 29.1.261 Dr N J Wood (appointed 24.6.20 Ind¢pendent EJimlTher Colin Bell FCCA Williams Denion Cyf Chart¢red C¢rtified Acco￿￿￿ Glasly Ffordd y Par¢ Parc M¢rni Ban￿r Gwynedd LL57 4FE Page 6

BRITISH GVNAECOLOGICAL CANCER SOCIETY REPORT OF THE TRUSTEFS FOR THE YEAR ENDED 31 DECEMBER 2025 Approved byor<krof the iN)ard of In￿te¢S on 29 S¢ptrmber 2026 8T￿ $i8ffd on its beh*lf by: T E J Ind- TnL8tee Pa8e 7

INDEPENDEPn EXAMINER'S REPORT TO THE TRUSTEES OF BRITISH GYNAECOLOGICAL CAf4CER SOCIETY Independent examlner'j T¢￿rt to th¢ tru$ltts of Brfttsh Gymaeeologieal Cancer Sockty I report ￿ the charity tr￿t¢e$ on my examitt81ion of the accounts ofBrilj5h G>ma¢cological C4tw Soci¢ty (the Trust) for the year ¢nd¢d 31 D¢c¢TDb¢r 2025. Responsibilities basi¥ of r¢port the charity trustees of tbe Tr￿81 YOU Are responsible for the preparntion of the a¢xounts in ac¢ordan¢e with the requirements of th¢ Chariii¢s A¢t2011 {)h¢ A¢fj. I report in reyct of my ¢xamination of th¢ Tnjsi's a¢¢OUntsca￿1¢d uT¥Jer Section 145 of the Act and in carrying oul my examination I have followcd 8ll a￿lICable Directions given by the Cthttrity Cornmis5ion under s￿tion 145{5Xb) of tho ACL Independent ¢xamlD¢r's $t8tement Since your ¢harity'8 ¥ross 1￿com¢ exceeded £250,0(￿ your cxllrniner must b2 a m¢mber of o lis*d b(dy. I confi that 18m qu81ifi¢d to undertak¢ the examination ixcaus¢ l aTh a w￿rnber of the Aswiation of Ch8rtered Certified Accountants, which is one of the l&¥l¢d IK)diE5. I have completed my examination. I conflmi that no m&i¢ria] matters hfft come to rny attention in Conneciion with the examination gtving me caw8e io b¢li¢v¢ thai in ony material rw¢ct.' aecouniing records were t￿t kept in respttt of Tntst as required by Section 130 of the Act; or the accounts do ￿t accord with those records. or the accounts do Thol comply with the applicabl¢ requirenMi$ con¢¢miftg th¢ forni atMI content of accounts set out in thc Charities (Accounts and Re[￿5) Re8ulation$ 2008 other than any requirement that the accounts 8iv¢ a true arKI fair view wljich is not a matter ¢oThsid¢r&l as parrof an inde￿1 examination. I have concerns and have eon% across w thher rnatt¢Tr in ¢onne¢tion with the exaTnination to which attention should be drawm in this report in order to enable a prnper und¢rstsJMling of the accounts to be r¢a¢hd. Colin Bell FCCA Williams De¢)ton Cyf Chartered Certified Accountsnts Glaslyn Ffordd y Pa Pa￿ Metsai B81J￿0[ LL57 4FE Pag¢ 8

BRITISH GYNAECOLOGICAL CANCER SOCIETY STATEME￿ OF FINANCIAL ACTivrriF3 FOR THE YEAR ENDED 31 DECEMBER 2025 2025 Tolxl fund5 2024 Total funds Unrestricl¢d Restricted Notes INCOME AND ENTK)WME]YIS FROM Charlt*bh #cllvltles To advan¢e ihe sci¢n¢¢ and art of 8yDattolo8ical onGology for th¢ ben¢fit of th¢ public 499J08 27JOO 527,008 403,115 Investment In￿Me 655 6,655 9,738 T•tAI 511fj163 27JIM) 533,663 412,853 EXPENDITURE ON Ch8rlt8ble 8¢tivltle5 To advance the 8ci¢nr¢ a￿A art of gyllae¢olo8i¢81 oncolo8y for the b¢nefrt of the publi¢ 57&804 05A20 644J84 5¢)2,229 NET INCOMEI(EXPENDATURE) Tr4nsfers behyeen funds (72,701) (24.660) (38,020) 24.660 (11ffj721) {89,376} Net m•vemeDt in {97J61) (13J60) (IlQ721 {89,376) RECONCILIATION OF FUNDS Total fijnds brought forward $32,863 13J611 5ffj223 635.599 TOTAL FUNDS CARRIED FORWARD 435,%2 435J02 546.223 cor4TINUING OPERATIONS All income and ¢xpendiiure has arisen from ¢oniinuing 2Ktivities'. The n(rt¢5 fo￿ part of these fLI]ancLlll statemts Page 9

BRrrisH GTrTIAECOLOGJCAL CANCER SOCIETY BALANCE SHEET 31 DECEMBER 2025 2025 Tot41 fundi 2024 Total fi]nd8 Unr¢stTiGted Restritt¢d Not&8 CURRENT ASSETS Dcbiors Cash at bank 129,963 421.558 129,963 421 J58 123.959 515.278 551521 551 J21 639,237 CREDITORS An￿￿￿1$ falling within onc ycar 10 {IIA019) (114019) (93.014) NET CURRENT ASSETS 435502 43S502 546,223 TOTAL ASSETS LFSS CURRENT LIABILITIES 435J02 435.sin 546223 NET ASSETS 435502 43S502 546223 FUNDS Unre$tri¢t¢d fuAIs RestrictEd fv[￿S 435A•2 532,863 13,360 TOTAL FUNDS 435,S•2 $46223 The fina￿181 statcrncnts w¢rt approved by the B(Ard of TrusteE5 aDd authori8ed foT Is￿e on 29 S¢pi¢rnber 2026 and were SI￿¢4 on its behalf by: TEJInd-T￿SIrt The notes fonn part of these finHn¢ial statement8 Page 10

BRITISH GYNAECOLIKICAL CANCER SOCIETY CASH FLOW STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2025 2025 2024 Notes Casb nows from uper¥dTrg 4etlvlties Cash generdted from operations (IOOJ75) {41,303) N¢t used in QP¢Tatins activitie5 (IOOJ7S) (41,303) C8$b Ilows from Inve5dng 4ctlwitie5 IDlertsl rtteived 655 9.738 Net cash provided by ijjvthing a¢iivities 6,655 9.738 Chlnge In ¢osh and (ash EqwIv8l¢nts I the ￿pOrtIng pcrSod Cash and ¢ash equiv•leDts t the beginnitsR of the rey)rtlng period (93.720) {31,565) 5JS278 546,843 Cd5h gNd cash equlvlENts a¢ the end or th¢ reporting perlod 421558 515278 Th¢ fomipart of these financial statements PJ8ell

RRJTISH CYNAECOLOGICAL CANCER SOCIETY NOTES TO THE CASH FU)W STATEMEPIT FOR THE YEAR ENDED 31 DECEMBER 2L)IS RECONCILIATION OF NET EXPENDITURE TO Nrf CASH FEA)W FROM OPERATING ACTIVITIES 2025 2024 Net ¢yp¢ndlture for tht r4￿rtIng period (aj per tbe thtement of FffiDAncial Actlvllks Adjustments for: Interest ￿e1Ve￿ I￿re45¢ in debtors Inc]Yase in ¢reditOTS (1111,721) {89,376} {fj.659 (0,003} 23,11114 19,738) (29.365) 87.176 Net e*5h used AD •p¢r8¢lons IIOilJ75) (41.303) ANALYSIS OF CHANGES IN NET FUNDS At 1.1.25 Cash flow At 31.12.25 r4et casb Cash at bat 515,278 (93,720) 421J58 515.278 (93.720> 421A58 Total SIS278 (93,7211} 421 J58 The notes fomi part of these financial stat¢mBnts Page 12

BRITISH CYNAECOLOGICAL CANCER SOCIETY PIOTES TO THE FINANCIAL STATEMEIY FOR THE YEAR ENDED 31 DECEMBER 2025 ACCOUNTING POLICIES BA&i of prepaTln# the statements The financial statcm¢nts of th¢ charity. which is a public benefit enlity undcr FRS 102, have b¢en pr¢pared in accordance MTrth the Charities SORP IFRS 1021 'Aecounting and Reporting by Ch3riti¢s.' St8tcment of Recomrncnded PTactice applicable ￿ ch￿ltieS preparing Ihcir account5 in accvrdan¢¢ with th¢ FinaDcial Reporting Stsndard applicable in the UK and Republic of Irelartd IFRS 1021 (effective l January 2019),, Finan¢ial Re￿nIng Stsndard 102 The FinatKial R¢w)rting Sta]Jdard applioble in thc UK and liepublic of Ireland, 8tyd the Charilie5 Act 2011. The flnancial statements have b¢¢n prepwr¢d under the hLStorical cost conv¢niion. is reco￿lS¢d when the charity has cnlltlt￿th to tl fmids, any performance conditions attached to income have been m¢L it is probable that the i￿ome wll bE received aTKi the amount call b¢ n￿sUr¢dre1i0￿Iy. Incorw from Govemmeni and other grants. Ththether 'capital' grdnts oi't¢v¢nu¢' 8Tant8 is recognised then the charity h&8 entitl¢mcnt to the funds, any p¢rfonnance condÉtions attached to the ￿￿￿¢$ hav¢ been m¢l it is Probable thai the inEOtne will be received and tk amount ean be reltably and is not defe￿ed. xpendlture And Im¢ov¢r•bl¢ Y8t Liabilities are re￿gnIsed as expenditure a5 soon as th¢r¢ is 4 l¢gal or ¢onstrnctive obli8alion LY)mtnittin¥ th¢ chatity ID ibal expenditttre. it is probable that a tT3n$fti of ee(>nomic benefits will be Tquired ID settlement and the amount of the obli8ation can be mE&sured reliably. Expendiwre is acwNnt¢d for OTh an accrua15 basis and has been classificd under headin85 that agwgote all cosi r¢]a¢ed io the category. Wkre wsts c#￿￿01 be dire¢dy attribut¢d lo particular headings they have ￿en allocated to aclivitics on a basis consi51￿1 with the use of resource5. Itrecov¢rable VAT 1$ ¢lW as a cost in the 5tstement of financial a¢tiviiie& Txxtlon The charity is exempt frorn corporation tax on its ¢h&rithble a¢tiviti¢s and is ryi5tered for VAT purposes. Fund JlC¢OUDIIDg Uw¢stri¢t¢d fvnds can be used in accord#T￿e wilh the charitable objectives at the discretion ofthe lThste£ Restricted futlds can only k uscd forpathculAr resrricted purtK>se5 within the objects of the Charity. Restrictions arise whEn specified by the Itonor or when funds are raised foT Particular testri¢*d purposes. Further ¢xplanation of the nature aDd PUfFdY5C of each fvrKi 15 irKlud¢d in th¢ notes to the financial stalcnKn INVESINENT INCOME 2025 2024 tkp)sit a¢eount inTrresi f4655 9,738 Page 13 continyed...

BRITISH GYNAECOLOGICAL CANCER SOCIETY NOT&8 TO THE FINANCIAL STATEMENTS- ¢oM¢l#ued FOR THE YEAR ENDED 31 DECEMBER 2025 INCOME FROM CHAluTAB￿ A￿1VITI￿8 2025 2024 A¢tivity To advancc the scietxt alld art or gy￿a￿l0&Y¢al oncology forthe b¢t)efii of the public Tv thE 5ci¢ncE a￿] art of gynaeKologi¢a] oneology foT the ktlefit of the public To advance the 5ciuKe aThl art of 8ynaecol08i￿j oftcology for the benefit of the pthli¢ To advance the ￿len¢e aTrJ art of 8ynattolo8ical ovoltl8y for th¢ be￿rit of the public To advAnce the SCie￿e aTrJ art of gynarfojo￿¢a] oftcology for the ￿n¢fil of the public To advancc the Science and art of 8ynaecolo8ical oncology for the benefit of th¢ p￿)11¢ To adv4ll¢e the science and art of 8ynaeeologi¢al on¢ology for the benefit of the public To advance the sciffl￿e and art of aecological oneolo8y foT the benefit of the pthlic 27WO 62.500 Spottsotships IJ 833 Dele8aie fees 17J91 Subviptions 63,024 56.1)38 ASM Socia] ProgrdmTne 11th53 8,230 ASM Dele￿Tr inwne 161A39 137.110 ASM sp)n40￿1P income 24Sffj17 120363 Slmthy irtwme 150 527.01)8 403.115 GraThts receive(L in¢lud¢d in th¢ abov¢, gr¢ 95 follows: 2025 2024 Merck Sknrp & Dohme (EThlometrical Cancer Audit) GlaxoSmithKline (EndollKtrial CancerAudit) Eisai (EThJometrial Cancer Audit) British A5sor. of Gynaecological PatholobTLS15 (Endornetrial can￿rA￿li1) Ev¢ Appeal (ET￿0￿c￿l8l Cancer Audit) Peaches Womb CancerTn]st Ilndornetrial ca￿er Audit) 30,IKrtI 20.IN)O 7.500 7.5( 27,Yl 62,500 P8g¢ 14 contLnue&..

BRITISH GYNAECOinGICAL CANCER SOCIETY NOTES TO THE FINANCIAL STATEMEiYfs- contljued FOR THE YEAR ENDED 31 DECEMBER 2025 CHARITABLE AcfJvJTIES COSTS SuppDrt Costs ( note S) Direct Costs Totsls To advance the science and ari ur gyna¢cological o¢KoW for the benef of the public 595,651 4&733 SUPPORT COSTS Man8g¢n*nt tosis Totals To advawe the science and art of gjnaecological ortology forthe benefit of th¢ publi¢ 31785 11948 48,733 INDEPENDENT EXAMINER'S FEES 2025 2024 Independent examiner% fees 104$ TRUSTEES. REMUNERATION AND BENEFrrs There no thistees. r¢r￿n¢￿tion or other IKn¢fits for lh¢ y¢8T eryled 31 Deeernber 2025 ￿)r for the year ¢Dd¢d 31 December 2024. Tru9ttt9' expetss 2025 2024 Tn]stees' expenses 3076 5.979 COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACflVTfiES Utwtricred nd Restrictcd Total fi￿dS INCOME AND ENDOWMENTS FROM Cbarltable attlvil(es To adva¢K¢ the s¢i¢n¢e and art of gjmaecological oncology for The benefii of th¢ public 340.615 62.5(h) 403.115 Investnxnt incorne 9.738 9,738 Totsl 350.353 62,500 412,853 EXPENDITURE ON Page IS ¢onlinued...

BRITISH CVNAECOLOGJCAL CANCER SOCIETY NOTES TO THE FJP4ANCIAL STA TEMENTS- ¢•mtlnutd FOR THE YEAR ENDED 31 DECEMBER 2025 COMPARATIVLS FOR THE STATEMENT OF FINANCIAL ACTivrfiES- ¢ontinued UtYe$tricted Restricttyj fjjnd Total funds ChiritBlJk a¢tlvl¢les To advance th¢ %ience and ort of naecolo8ical oncolo8y for th¢ b¢n¢fit of the public 453,089 49,140 502229 NET INCOMEI(EXPENDITURE) (102.736) 13,360 (89.376) RECONCILIATION OF FUNDS Total fvnds btought forward 635,599 635.599 TOTAL FUNDSCARRIED FORWARD 532,863 13J60 546,223 DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR 2025 2024 Othcr debtor5 VAT 98,861 67J13 5.566 51,080 31,102 129,963 123.959 111. CREDITORS: AMOUN13 FALLING DUE MryfHIN ONE YEAR 2025 2024 VAT Other creditors Def￿red incoTh]e 61J411 44,045 2,645 46,759 43.755 2.$00 116I19 93,014 Pag¢ 16 ¢ontinlled...

BRITISH GYNAECOLOGICAL CANCER SOCIETY NOTES TO THE FINANCIAL STATEMENtS- wlltlnyed FOR THE YEAR ENDED 31 DECEMBER 21125 ii. MOVEMENf IN FUI¥DS Net Transfers At 31.12.25 At 1.125 in funds funds restfftted lind¥ General S32J63 (72,701) (24ffj60) 435302 Restricled f￿ndS Endometrial CatK¢r Audii 13J6 (38,020) 24,660 TOTAL FUNDS 54A223 {110,72J} 435,502 Net nM)vement in furtds, included in th¢ above as fo]lows.' In¢tsmin8 Resource5 Movemt in fi]ry15 Unrestrleted funds General fund 9)6,103 (378064) (72.701) Réstrleted funds Endometrial CarKer Audit 27,$00 (65,520) (3&0211) TOTAL FUNDS (644,3841 (110,721} Ct)mprn¢fvu for movennt In fund5 Nel nKTrv¢ment in ￿ndS At 31.12.24 At 1.1.24 Unrettrlcied 635J99 102,736} 532,803 R¢strict¢d funds Endomctrial CaKYr Audii 13.360 13J60 TOTAL FUNDS 635) (89,376) 546,223 P¥ge 17

BRITISH GYNAECOLOGICAL CANCER SOCIETY NOTES TO THE FJIYANCIAL STATEMENTS- contthued FOR THE YEAR ENDED 31 DECEMBER 2025 MOVEMENT IN FUNDS- tontinued C(mparative Jkt movement in futyd5 Tr￿l￿d￿ in the above are as folloms". InCO￿]ng rttourees Resources exp¢txled Movement Unrestricted fund 350353 (453.089) (102,736) Re5trlcted fund$ EThJometrial CatKcr Audit 62J {49,140) 13J60 TOTAL FUNDS 412.853 (502229) (89J761 A current 12 months and prky Itar 12 ftM)nths combined wsi¢i¢)n is #s follows.. Nct moventtt in fuuds Transfers betwcen At 31.12.25 A¢ l.124 UDT¢$trkted fund 635,599 (175.437) (24.660) 435.502 Restricted fund5 Endometrial Canccr Audit (24.6601 24.660 TOTAL FUNDS 635 J99 (200,0971 435J02 Net rnovement in f￿d$ inch￿ed in the aly)ve are a5 follow5.' ItLCOtning resources Resou￿¢$ cxpended MoY¢m¢ni in fiuJd5 Uttre5¢ri¢ted fund 856J16 (1.031,953) 1175.437) Regtrleied thd$ End0￿etrIal Ca￿erAUdit 90.(KIO (114.660) {24.660) TOTAL FUNDS 946316 (1,146.613) I2¢￿.097> PDrpose of the Restrltted FU￿￿$ Endom¢trtal C•nttr A￿lIt The BGCS hav¢ commissioned a two year retrospecitve avdit into the IT￿]denCe. ￿A)rtality and treatment of F￿dome[rIal ¢an¢er in the UK. The Endornetrial Cancer Audit Pmject {ECAP) has b¢cn co-funded by BGCS and oihei chaTi¢i¢5 a5 well a5 receiving grants from som¢ pbanmceutical compfinie5.The proj¢¢i will aid the Gwwecolo8itral Ca￿tI fDrnmunity ITh pla[￿l￿g appropriat¢ tr¢4tllKM and assess if ih¢r¢ ar¢ r¢8ional variations in ¢he management of endojnetrial cancer within the UK Ph8¢ 18 ¢orttinucd...

BRrrisH GYNAECOLOGICAL CANCER SOCIETY NOTES TO THE FINANCIAL STATEMENfs- eoNtl*ued FOR THE YEAR ENDED 31 DECEMBER 2025 12. RELATED PARTY DISCLL>SURES Due to the nature of the charitls operdiions And composition of th¢ l)oard of knstee5 and membership both trusttts and Tnembers will pay subscriptions and fe¢s lo th¢ Charity, other thm these no material transactions have been identified which should be disclos¢d. PAg¢ 19